CIK 0001006045 · Non-accelerated filer<br>Smaller reporting company
IRIDEX CORP
Sign in to watch- Ticker
- IRIX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Jan 3
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770210467
- Phone
- 6509404700
- Business address
- 1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA, 94043
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 20,000 shares at $0.97 ($19,372)
- 4 Open-market buy President and CEO bought 250 shares at $0.96 ($240)
- 4 Open-market buy Director bought 30,000 shares at an average $0.97 ($29,121)
- 4 Open-market buy Chief Financial Officer bought 245 shares at $0.97 ($236)
- 4 Open-market buy Chief Financial Officer bought 835 shares at an average $0.98 ($822)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $0.97 ($1,455)
- 4 Open-market buy Chief Financial Officer bought 200 shares at an average $1.00 ($199)
- 4 Open-market buy Chief Financial Officer bought 200 shares at $0.99 ($197)
- 4 Open-market buy Chief Financial Officer bought 200 shares at $0.95 ($190)
- 4 Open-market buy Chief Financial Officer bought 100 shares at $1.00 ($100)
- 4 Shares withheld for taxes President and CEO gave up 14,310 shares (to pay taxes)
- 4 Open-market buy Chief Financial Officer bought 100 shares at $1.00 ($100)
- 4 Open-market buy Chief Financial Officer bought 200 shares at an average $1.00 ($201)
- 4 Open-market buy Director bought 17,500 shares at an average $1.09 ($19,009)
- 4 Open-market buy Chief Financial Officer bought 460 shares at $1.10 ($506)
- 4 Open-market buy Chief Financial Officer bought 1,305 shares at an average $1.11 ($1,451)
- 4 Open-market buy Chief Financial Officer bought 100 shares at $1.16 ($116)
- 4 Open-market buy Chief Financial Officer bought 100 shares at $1.15 ($115)
Page 5 of 31 · 608 filings